• The tests carried out in Africa are economically interesting for companies but are at risk for Africans. Health rules are much less controlled, insurance is scarce, clinical trials are sometimes not finished. This is a controversial subject and these techniques are not unanimous in a time when the trend is towards an egalitarian society. However, not allowing Africans these clinical trials is a barrier to the development of their country. This is why associations like GFAOP are establishing themselves in Africa. Legitimate and approved, they make it possible to provide care to people who need it but also educate in medicine to allow Africa to become more and more independent in this area. The GFAOP association has already helped treat more than 11,000 children with cancer, but this represents only 15% of the African population, which is still very little.

About Rick1234Obis

Leave a Reply